about
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology...
Read More
114.39
0.10
(0.09%)
818.3K
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Arcellx Inc is on 20 Mar 2026 for the purpose of Arcellx Inc Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Arcellx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..